A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough

Hydrocodone/chlorpheniramine is a prescription opioid licensed in the USA for the relief of cough and upper respiratory symptoms associated with allergy or cold in adults, previously contraindicated in children aged < 6 years. We present findings from a modern benefit risk review of hydrocodone/c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sloan, Victor S., Jones, Alphia, Maduka, Chidi, Bentz, Jürgen W. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520422/
https://www.ncbi.nlm.nih.gov/pubmed/31073977
http://dx.doi.org/10.1007/s40801-019-0152-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520422/
https://www.ncbi.nlm.nih.gov/pubmed/31073977
http://dx.doi.org/10.1007/s40801-019-0152-6

Ejemplares similares